ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,581Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1000

$1.77M Total Retail Price of All Prescriptions

Rank: 10 out of 1000

792 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 792 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

45% of this provider’s 792 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 16,668 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,149 930 S3 1 1
OMEPRAZOLE 1,168 696 2 2
FUROSEMIDE 950 644 3 7
AMLODIPINE BESYLATE 715 500 4 6
LEVOTHYROXINE SODIUM 677 422 5 4
SIMVASTATIN 648 468 6 3
METFORMIN HCL 620 374 7 8
FENOFIBRATE 618 361 8 55
ZOLPIDEM TARTRATE 584 214 9 16
POTASSIUM CHLORIDE 491 310 10 10
LISINOPRIL 462 310 11 5
PRAVASTATIN SODIUM 429 227 12 12
WARFARIN SODIUM 421 302 13 22
MELOXICAM 407 229 14 14
CITALOPRAM HBR 394 240 15 17
TRAMADOL HCL 376 194 16 13
CRESTOR 367 171 17 30
GABAPENTIN 344 166 18 11
ATORVASTATIN CALCIUM 337 219 19 18
TIZANIDINE HCL 293 73 20 76
POLYETHYLENE GLYCOL 3350 274 229 21 69
PROMETHAZINE HCL 273 72 R 22 54
METOPROLOL SUCCINATE 267 166 23 21
KLOR-CON M20 257 188 24 66
NEXIUM 256 76 25 23
LYRICA 244 95 26 47
MIRTAZAPINE 239 212 27 56
ESCITALOPRAM OXALATE 239 173 27 60
LOSARTAN-HYDROCHLOROTHIAZIDE 232 120 29 38
SINGULAIR 219 76 30 84
HYDROCHLOROTHIAZIDE 212 129 31 9
LOSARTAN POTASSIUM 210 120 32 25
METOPROLOL TARTRATE 207 162 33 19
NAMENDA 204 173 34 43
CARVEDILOL 199 126 35 15
LANTUS 198 104 36 68
CYCLOBENZAPRINE HCL 196 69 R 37 39
CLOPIDOGREL 195 136 38 35
ALENDRONATE SODIUM 173 122 39 57
ISOSORBIDE MONONITRATE ER 172 134 40 71
AZITHROMYCIN 172 79 40 36
JANUVIA 170 146 42 85
ROPINIROLE HCL 166 80 43 82
EXELON 161 159 44 108
PANTOPRAZOLE SODIUM 161 97 44 28
PLAVIX 158 110 46 49
ENDOCET 157 98 S2 47 107
TAMSULOSIN HCL 157 89 47 33
DONEPEZIL HCL 151 125 49 32
ALLOPURINOL 147 99 50 31
METHADONE HCL 146 24 S2 51 161
TRAZODONE HCL 142 45 52 29
CYMBALTA 138 72 53 53
CLONIDINE HCL 136 95 54 27
SERTRALINE HCL 136 49 54 26
CIPROFLOXACIN HCL 135 87 56 46
RANITIDINE HCL 128 47 57 37
MONTELUKAST SODIUM 125 46 58 132
FLUTICASONE PROPIONATE 117 50 59 40
HUMALOG 117 57 59 192
ADVAIR DISKUS 108 45 61 65
ATENOLOL 107 51 62 24
GLIMEPIRIDE 106 65 63 34
DICLOFENAC SODIUM 105 56 64 123
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 69 65 20
SYMBICORT 100 42 66 149
SPIRONOLACTONE 100 41 66 78
OXYCODONE HCL-ACETAMINOPHEN 97 50 S2 68 138
FLUOXETINE HCL 96 20 69 51
LEXAPRO 94 62 70 196
DIVALPROEX SODIUM 91 58 71 113
BYSTOLIC 90 35 72 126
BISOPROLOL-HYDROCHLOROTHIAZIDE 90 58 72 101
TRICOR 89 47 74 141
FLUCONAZOLE 88 38 75 102
CEFUROXIME 88 40 75 133
NYSTATIN 85 49 77 182
DOXEPIN HCL 85 36 77 176
CELEBREX 85 58 77 98
CARBIDOPA-LEVODOPA 84 80 80 116
AZOR 83 31 81 334
PEN NEEDLE 82 23 82 165
LANTUS SOLOSTAR 82 17 82 120
AMITRIPTYLINE HCL 81 57 R 84 45
AMLODIPINE BESYLATE-BENAZEPRIL 81 40 84 59
ZETIA 80 60 86 95
DIOVAN 80 76 86 67
VENLAFAXINE HCL ER 78 0 88 124
LEVOFLOXACIN 77 46 89 73
LOVAZA 77 38 89 148
LIDODERM 77 39 89 220
MECLIZINE HCL 76 46 92 80
METFORMIN HCL ER 76 44 92 44
PROAIR HFA 73 16 94 50
QUETIAPINE FUMARATE 72 33 95 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 43 95 70
PAROXETINE HCL 70 43 97 63
ACTOPLUS MET 69 56 98 319
KLOR-CON M10 69 53 98 216
OXYBUTYNIN CHLORIDE ER 67 58 100 157
BISOPROLOL FUMARATE 66 51 101 209
PREMARIN 66 25 R 101 109
TRILIPIX 65 20 103 218
SPIRIVA 64 31 104 64
METOCLOPRAMIDE HCL 63 41 105 99
LIPITOR 63 35 105 170
ONDANSETRON HCL 62 55 107 204
ACTOS 62 24 107 119
HYDRALAZINE HCL 62 45 107 74
FENTANYL 62 52 S2 107 100
DIGOXIN 59 50 111 52
OXYCONTIN 59 46 S2 111 166
RAMIPRIL 58 56 113 77
JANUMET 55 41 114 195
METHOCARBAMOL 55 15 R 114 79
RISPERIDONE 54 24 116 87
DEXILANT 53 17 117 248
DIOVAN HCT 52 33 118 96
BENICAR 52 30 118 263
AMIODARONE HCL 52 51 118 178
TORSEMIDE 52 37 118 137
MICARDIS 52 38 118 324
KOMBIGLYZE XR 52 25 118 344
VENTOLIN HFA 51 25 124 83
ESTRADIOL 51 33 R 124 114
BACLOFEN 51 21 124 129
TEKTURNA 50 42 127 446
LEVEMIR FLEXPEN 50 0 127 205
CARISOPRODOL 50 0 R 127 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.